| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ORIGINAL ARTICLES |
Departments of Psychiatry (P.N., P.S.), Radiology (A.S.), and Neurology (A.H.), CharitéHochschulmedizin Berlin, Campus Benjamin Franklin, Berlin, Germany.
Address correspondence and reprint requests to Dr. Peter Neu, CharitéHochschulmedizin Berlin, Campus Benjamin Franklin, Klinik und Poliklinik für Psychiatrie und Psychotherapie, Eschenallee 3, 14050 Berlin, Germany. E-mail: peter.neu{at}medizin.fu-berlin.de
OBJECTIVE: There are a growing number of reports that depression may increase the risk of stroke. Little is known, however, about the pathophysiologic mechanisms underlying this association. Cerebrovascular reactivity (CVR) reflects the compensatory dilatory capacity of cerebral arterioles to a dilatory stimulus and is an important mechanism to provide constant cerebral blood flow. We hypothesized that CVR is reduced in patients with major depression, thus contributing to the association between depression and stroke.
METHODS: We assessed CVR in 33 patients with unipolar depression and 26 healthy controls by calculating the increase in cerebral blood flow velocity after stimulation with acetazolamide. Blood flow velocities were measured by transcranial Doppler ultrasound.
RESULTS: Cerebrovascular reactivity was significantly reduced in depressed patients. Smoking was also associated with a significant reduction in CVR, whereas age and gender had no significant influence.
CONCLUSIONS: Cerebrovascular reactivity appears to be impaired in major depression. Further studies should clarify the mechanisms leading to this reduced CVR.
Key Words: cerebrovascular reactivity, ultrasound, major depression.
Abbreviations: ACZ = acetazolamide;; CVR = cerebrovascular reactivity;; MFV = mean flow velocity.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |